Research
Energy balance
The changes to the eGFR formula may impact eligibility and/or dosing for antiobesity medications.
Practitioners should be aware of how the new eGFR formula affects treatment options for obesity.
StrongSupportsmedium confidence
These changes may impact eligibility and/or dosing for antiobesity medications.
Why this rating
Based on the implications drawn from the study's findings.
Source
Impact of refitted <scp>race‐free eGFR</scp> formula on obesity pharmacotherapy options
Babak J. Orandi et al. · Obesity · 2022
DOI 10.1002/oby.23542
cohort · n=126127322Cited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →